Pure Global

Elecsys Anti-HCV II - Albania Medical Device Registration

Access comprehensive regulatory information for Elecsys Anti-HCV II in the Albania medical device market through Pure Global AI's free database. This Invitro medical device is manufactured by Roche Diagnostics GmbH, Sandhofer Strasse 116, D-68305 Mannheim. The device was registered on April 28, 2022.

This page provides complete registration details including product model (Elecsys Anti-HCV II: 08836981190; 08837031190; 08837058190), manufacturer information, risk classification, and regulatory compliance data from the official Albania medical device database. Pure Global AI offers free access to Albania's medical device registry, helping global MedTech companies navigate Albania regulations efficiently.

Free Database
Powered by Pure Global AI
Albania Official Data
Invitro
Elecsys Anti-HCV II
Albania Medical Device Registration
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Information

Reagent per matjen e hepatitit C ne plazmen humane

Device Classification
Risk Class
Invitro
Product Model
Elecsys Anti-HCV II: 08836981190; 08837031190; 08837058190
Product Name
Elecsys Anti-HCV II
Registration Information
Registration Date
April 28, 2022
Analysis ID
11870